Style | Citing Format |
---|---|
MLA | Nateghi S, et al.. "Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review." International Journal of Hematology-Oncology and Stem Cell Research, vol. 19, no. 1, 2025, pp. 69-74. |
APA | Nateghi S, Rasooli A, Moaddabshoar L, Panahi Z, Rostami MR (2025). Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review. International Journal of Hematology-Oncology and Stem Cell Research, 19(1), 69-74. |
Chicago | Nateghi S, Rasooli A, Moaddabshoar L, Panahi Z, Rostami MR. "Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review." International Journal of Hematology-Oncology and Stem Cell Research 19, no. 1 (2025): 69-74. |
Harvard | Nateghi S et al. (2025) 'Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review', International Journal of Hematology-Oncology and Stem Cell Research, 19(1), pp. 69-74. |
Vancouver | Nateghi S, Rasooli A, Moaddabshoar L, Panahi Z, Rostami MR. Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review. International Journal of Hematology-Oncology and Stem Cell Research. 2025;19(1):69-74. |
BibTex | @article{ author = {Nateghi S and Rasooli A and Moaddabshoar L and Panahi Z and Rostami MR}, title = {Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review}, journal = {International Journal of Hematology-Oncology and Stem Cell Research}, volume = {19}, number = {1}, pages = {69-74}, year = {2025} } |
RIS | TY - JOUR AU - Nateghi S AU - Rasooli A AU - Moaddabshoar L AU - Panahi Z AU - Rostami MR TI - Cardiac Considerations in Hematopoietic Stem Cell Transplantation (Hsct) for Transfusion-Dependent Thalassemia: A Review JO - International Journal of Hematology-Oncology and Stem Cell Research VL - 19 IS - 1 SP - 69 EP - 74 PY - 2025 ER - |